{"nctId":"NCT03196791","briefTitle":"Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient","startDateStruct":{"date":"2017-10-10","type":"ACTUAL"},"conditions":["Gastric Cancer","Obesity"],"count":196,"armGroups":[{"label":"Deep neuromuscular block group","type":"EXPERIMENTAL","interventionNames":["Drug: Sugammadex Sodium"]},{"label":"Moderate neuromuscular group","type":"EXPERIMENTAL","interventionNames":["Drug: Sugammadex Sodium"]}],"interventions":[{"name":"Sugammadex Sodium","otherNames":["BridionÂ®, MSD"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Gastric cancer patients with laparoscopic subtotal gastrectomy\n* 19-75 years\n* Body mass index(BMI) \\> 25kg/m2\n* American Society of Anesthesiologists I-III\n\nExclusion Criteria:\n\n* American Society of Anesthesiologists Class IV\n* End stage renal disease (ESRD) patient\n* Patients with allergy to muscle relaxants\n* Patients with diseases that may affect muscle relaxation","healthyVolunteers":false,"sex":"ALL","minimumAge":"19 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Retrieved Lymph Nodes Per Participant","description":"Number of retrieved lymph nodes per participant, which was reported on final pathology report, after completing the laparoscopic surgery","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"44.6","spread":"17.5"},{"groupId":"OG001","value":"41.5","spread":"16.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"49.2","spread":"18.6"},{"groupId":"OG001","value":"39.2","spread":"13.3"}]}]}]},{"type":"SECONDARY","title":"Surgical Rating Score (SRS)","description":"Surgical rating score (SRS) at Four anatomical area during LN dissection\n\nDuring surgery, the surgeon reported the SRS based on the Leiden surgical rating scale (1=extremely poor, 2=poor, 3=acceptable, 4=good, 5=optimal) for each anatomical landmark (LN stations 4sb, 6, and 5 and the suprapancreatic area).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.4","spread":"0.9"},{"groupId":"OG001","value":"4.3","spread":"0.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.2","spread":"1.0"},{"groupId":"OG001","value":"4.1","spread":"1.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.2","spread":"0.9"},{"groupId":"OG001","value":"4.2","spread":"0.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.1","spread":"1.0"},{"groupId":"OG001","value":"4.0","spread":"1.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.2","spread":"0.9"},{"groupId":"OG001","value":"4.2","spread":"0.9"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With at Least One Interruption Event","description":"Interrupted event by patient movement, coughing, muscle spasm during operation","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19","spread":null},{"groupId":"OG001","value":"34","spread":null}]}]}]},{"type":"SECONDARY","title":"Intraoperative Blood Loss Amount","description":"Amount of bleeding during operation","paramType":"MEDIAN","dispersionType":"Full Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"77.5","spread":null},{"groupId":"OG001","value":"74.2","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":98},"commonTop":[]}}}